GW Pharma CEO: More education needed on real health benefits of drugs derived from cannabis

"We're really at the beginning of this journey," GW Pharmaceuticals CEO Justin Gover tells CNBC's Jim Cramer.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.